Bausch + Lomb Corporation

BLCO ·Healthcare, Medical Devices, Ontario, Canada
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $5.10B $4.79B $4.15B $3.77B $3.77B $3.41B
Cost of Revenue — — — — — —
Gross Profit — — — — — —
Gross Margin — — — — — —
Operating Expenses
Research & Development — — — — — —
SG&A Expense $2.23B $2.08B $1.74B $1.48B $1.39B $1.25B
Operating Income $113.0M $162.0M $130.0M $207.0M $329.0M $260.0M
Operating Margin 2.2% 3.4% 3.1% 5.5% 8.7% 7.6%
Interest Expense $421.0M $399.0M $283.0M $146.0M $0 $0
Pretax Income $-317.0M $-234.0M $-166.0M $73.0M $318.0M $290.0M
Income Tax Expense $35.0M $71.0M $82.0M $58.0M $125.0M $307.0M
Net Income $-360.0M $-317.0M $-260.0M $6.0M $182.0M $-18.0M
Net Margin -7.1% -6.6% -6.3% 0.2% 4.8% -0.5%
EPS (Basic) $-1.02 $-0.90 $-0.74 $0.02 $0.52 $-0.05
EPS (Diluted) $-1.02 $-0.90 $-0.74 $0.02 $0.52 $-0.05
Shares Outstanding (Basic) 353.8M 351.8M 350.5M 350.0M 350.0M 350.0M
Shares Outstanding (Diluted) 353.8M 351.8M 350.5M 350.2M 350.0M 350.0M
Dividends Per Share — — — — — —